Product category:
Nucleic acid sequencing and synthesis
News Release from: Agilent Technologies Europe | Subject: Oligo Library Synthesis (OLS)
Edited by the Laboratorytalk Editorial
Team on 12 February 2008
Effort to streamline high-throughput
sequencing
Broad Institute researchers present findings at Advances in Genome and Biology Technology conference about using oligo libraries to identify mutations
Agilent Technologies has announced that findings stemming from the use of a novel method to further increase the value of high-throughput DNA sequencing were presented at the Advances in Genome and Biology Technology (AGBT) conference The method combines oligonucleotide libraries developed by Agilent with the Broad Institute of MIT and Harvard's production scale sequencing expertise, creating an efficient and highly multiplexed technique to capture targets for sequencing from genomic DNA
This article was originally published on Laboratorytalk on 30 Jun 2008 at 8.00am (UK)
Related stories
Agilent updates CGH microarray software
For large-scale experiments, Agilent DNA Analytics 4.0 can process more than 100 microarrays (244K), helping users easily compare data and visualise patterns
Agilent upgrades EZChrom Elite for China and Japan
The software is now localised into Chinese and Japanese, features a single walk-up sample entry screen and offers updated workstation compliance
Recent advances in sequencing technology have increased the speed of data acquisition.
However, without accompanying improvements in the ability to select relevant portions of the genome, i.e., specific exons or chromosomal regions, the technology cannot achieve its full potential in studying the relationships between genes and diseases.
Oligo Library Synthesis (OLS) provides, for the first time, great promise for eliminating this bottleneck by efficiently synthesising custom mixtures of up to 55,000 different oligonucleotides, up to 200bp in length, in a single tube.
Further reading
New standard for validating machine-tool accuracy
Agilent Technologies has introduced its new 5530 Dynamic Calibrator, a laser-based calibration system for measuring machine-tool and coordinate-measuring-machine (CMM) accuracy
High-res scanner for current, next-gen microarrays
Agilent Technologies latest version DNA Microarray Scanner employs SureScan high resolution technology to deliver high resolution and rapid scan times for current and next-generation microarrays
Industry's most inert capillary GC columns
Agilent Technologies has introduced what it says are the industry's most inert family of capillary gas chromatography (GC) columns, the Agilent J+W Ultra Inert Capillary GC columns
"Agilent's robust oligonucleotide synthesis capabilities enable us to make very long oligos," said Yvonne Linney, vice president and general manager, genomics at Agilent.
"This, along with our greatly expanded portfolio of reagents, allows us to rapidly expand our footprint in genomics and life sciences in general.
"It's extremely gratifying to see these combined capabilities, benefitting the research community in applications such as next-generation sequencing".
"Our work with Agilent has allowed us to accelerate our development of these techniques," said Chad Nusbaum, co-director of the genome sequencing and analysis programme at the Broad Institute, lead investigator on this collaboration.
"We prepare a labelled derivative of Agilent's oligo libraries to use for direct capture of target sequences by hybridisation.
"The method is highly multiplexed, with a simple, efficient and inexpensive laboratory process, thus overcoming the sample preparation bottleneck".
The Broad Institute's DNA sequencing group took advantage of the flexibility and quality of Agilent's SurePrint inkjet oligonucleotide manufacturing technology.
The institute is an early-access user of OLS, which Agilent plans to launch commercially later this year.
The commercial offering will include bioreagents that will be compatible with a variety of next-generation sequencing platforms".
"We appreciate working with the genome sequencing centre of The Broad Institute," said Emily LeProust, Agilent manager of chemistry development.
"This collaboration benefits from their many years at the forefront of sequencing technology, and their vision of the potential for using sequence information to solve biological problems.
"For several years now, Agilent has been developing methods of synthesising high-fidelity long oligonucleotides.
"Ushering this application to a point where it answers very important biological question is very gratifying.".
• Agilent Technologies Europe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
